Literature DB >> 18386012

Detection of hypervascular malignant foci in borderline lesions of hepatocellular carcinoma: comparison of dynamic multi-detector row CT, dynamic MR imaging and superparamagnetic iron oxide-enhanced MR imaging.

Rieko Shinmura1, Osamu Matsui, Masumi Kadoya, Satoshi Kobayashi, Noboru Terayama, Junichiro Sanada, Hiroshi Demachi, Toshifumi Gabata.   

Abstract

The study object was to retrospectively compare the detection rate of hypervascular foci visualized by CT during hepatic arteriography (CTHA) in borderline nodules, which was observed upon cirrhotic livers, on dynamic MDCT, dynamic gadolinium-enhanced MR (dynamic MR), and SPIO-enhanced MR imaging. Eighty-five nodules in 49 patients with cirrhosis were evaluated. When a part of the nodule showed hyperdensity relative to the surrounding areas of the nodule on CTHA, it was defined as "hypervascular focus." The relationships between the dynamic MDCT and dynamic MR and SPIO-enhanced MR imaging findings of these foci were analyzed using X(2) test. Hypervascular foci were detected in 17 (53%) of 32 on the arterial dominant phase of dynamic MDCT, in 19 (37%) of 51 on the arterial dominant phase of dynamic MR and in 6 (26%) of 23 on SPIO-enhanced MR imaging. Arterial dominant phase of dynamic MDCT demonstrated a significantly higher detection rate of hypervascular foci less than 5 mm in diameter than did dynamic and SPIO MR imaging (p<0.05). Hypervascular foci in borderline nodules could be better visualized by dynamic MDCT than by gadolinium- and SPIO-enhanced MR imaging. Dynamic MDCT is recommended for the follow-up examination of hypovascular borderline lesions.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18386012     DOI: 10.1007/s00330-008-0954-5

Source DB:  PubMed          Journal:  Eur Radiol        ISSN: 0938-7994            Impact factor:   5.315


  15 in total

1.  Benign and malignant nodules in cirrhotic livers: distinction based on blood supply.

Authors:  O Matsui; M Kadoya; T Kameyama; J Yoshikawa; T Takashima; Y Nakanuma; M Unoura; K Kobayashi; R Izumi; M Ida
Journal:  Radiology       Date:  1991-02       Impact factor: 11.105

2.  Multicentric independent development of hepatocellular carcinoma revealed by analysis of hepatitis B virus integration pattern.

Authors:  M Sakamoto; S Hirohashi; H Tsuda; Y Shimosato; M Makuuchi; Y Hosoda
Journal:  Am J Surg Pathol       Date:  1989-12       Impact factor: 6.394

3.  Correlation between the blood supply and grade of malignancy of hepatocellular nodules associated with liver cirrhosis: evaluation by CT during intraarterial injection of contrast medium.

Authors:  M Hayashi; O Matsui; K Ueda; Y Kawamori; M Kadoya; J Yoshikawa; T Gabata; T Takashima; A Nonomura; Y Nakanuma
Journal:  AJR Am J Roentgenol       Date:  1999-04       Impact factor: 3.959

Review 4.  Terminology of nodular hepatocellular lesions.

Authors: 
Journal:  Hepatology       Date:  1995-09       Impact factor: 17.425

5.  Hepatocellular carcinoma in cirrhosis: enhancement patterns at dynamic gadolinium- and superparamagnetic iron oxide-enhanced T1-weighted MR imaging.

Authors:  Amelie M Lutz; Jürgen K Willmann; Kerstin Goepfert; Borut Marincek; Dominik Weishaupt
Journal:  Radiology       Date:  2005-09-28       Impact factor: 11.105

6.  'Atypical adenomatous hyperplasia' in liver cirrhosis: low-grade hepatocellular carcinoma or borderline lesion?

Authors:  Y Nakanuma; T Terada; S Terasaki; K Ueda; A Nonomura; E Kawahara; O Matsui
Journal:  Histopathology       Date:  1990-07       Impact factor: 5.087

7.  [Tumor hemodynamics in hepatic nodules associated with liver cirrhosis: relationship between cancer progression and tumor hemodynamic change].

Authors:  M Kudo; S Tomita; H Kashida; J Mimura; Y Okabe; M Hirasa; Y Ibuki; H Komori; A Orino; A Todo
Journal:  Nihon Shokakibyo Gakkai Zasshi       Date:  1991-08

8.  Nodule-in-nodule appearance of hepatocellular carcinomas: comparison of gadolinium-enhanced and ferumoxides-enhanced magnetic resonance imaging.

Authors:  Satoshi Goshima; Masayuki Kanematsu; Masayuki Matsuo; Hiroshi Kondo; Hiroki Kato; Ryujiro Yokoyama; Hiroaki Hoshi; Noriyuki Moriyama
Journal:  J Magn Reson Imaging       Date:  2004-08       Impact factor: 4.813

9.  Progression to hypervascular hepatocellular carcinoma: correlation with intranodular blood supply evaluated with CT during intraarterial injection of contrast material.

Authors:  Makiko Hayashi; Osamu Matsui; Kazuhiko Ueda; Yasuhiro Kawamori; Toshifumi Gabata; Masumi Kadoya
Journal:  Radiology       Date:  2002-10       Impact factor: 11.105

10.  Vascular supply in adenomatous hyperplasia of the liver and hepatocellular carcinoma: a morphometric study.

Authors:  K Ueda; T Terada; Y Nakanuma; O Matsui
Journal:  Hum Pathol       Date:  1992-06       Impact factor: 3.466

View more
  6 in total

1.  Incidence for progression of hypervascular HCC in hypovascular hepatic nodules showing hyperintensity on gadoxetic acid-enhanced hepatobiliary phase in patients with chronic liver diseases.

Authors:  Megumi Matsuda; Takaharu Tsuda; Shinji Yoshioka; Shigetoshi Murata; Hiroaki Tanaka; Masashi Hirooka; Yoichi Hiasa; Teruhito Mochizuki
Journal:  Jpn J Radiol       Date:  2014-05-24       Impact factor: 2.374

Review 2.  Asia-Pacific clinical practice guidelines on the management of hepatocellular carcinoma: a 2017 update.

Authors:  Masao Omata; Ann-Lii Cheng; Norihiro Kokudo; Masatoshi Kudo; Jeong Min Lee; Jidong Jia; Ryosuke Tateishi; Kwang-Hyub Han; Yoghesh K Chawla; Shuichiro Shiina; Wasim Jafri; Diana Alcantara Payawal; Takamasa Ohki; Sadahisa Ogasawara; Pei-Jer Chen; Cosmas Rinaldi A Lesmana; Laurentius A Lesmana; Rino A Gani; Shuntaro Obi; A Kadir Dokmeci; Shiv Kumar Sarin
Journal:  Hepatol Int       Date:  2017-06-15       Impact factor: 6.047

3.  Hepatocellular carcinoma: consensus recommendations of the National Cancer Institute Clinical Trials Planning Meeting.

Authors:  Melanie B Thomas; Deborah Jaffe; Michael M Choti; Jacques Belghiti; Steven Curley; Yuman Fong; Gregory Gores; Robert Kerlan; Phillipe Merle; Bert O'Neil; Ronnie Poon; Lawrence Schwartz; Joel Tepper; Francis Yao; Daniel Haller; Margaret Mooney; Alan Venook
Journal:  J Clin Oncol       Date:  2010-08-02       Impact factor: 44.544

4.  Hemodynamics and progression of a hypervascular focus in a borderline lesion of hepatocellular carcinoma: analysis by angiography-assisted CT and histopathology.

Authors:  Tamao Endo; Kazuto Kozaka; Satoshi Kobayashi; Junichiro Sanada; Wataru Koda; Tetsuya Minami; Azusa Kitao; Norihide Yoneda; Yasuni Nakanuma; Toshifumi Gabata; Osamu Matsui
Journal:  Jpn J Radiol       Date:  2013-12-12       Impact factor: 2.374

5.  Risk of hypervascularization in small hypovascular hepatic nodules showing hypointense in the hepatobiliary phase of gadoxetic acid-enhanced MRI in patients with chronic liver disease.

Authors:  Megumi Takechi; Takaharu Tsuda; Shinji Yoshioka; Shigetoshi Murata; Hiroaki Tanaka; Masashi Hirooka; Teruhito Mochizuki
Journal:  Jpn J Radiol       Date:  2012-09-22       Impact factor: 2.374

6.  Intravital assessment of angioarchitecture in rat hepatocellular nodules using in vivo fluorescent microscopy.

Authors:  Yi Liu; Tao Lu; Congcong Wang; Hui Li; Ke Xu; Peiling Li
Journal:  Quant Imaging Med Surg       Date:  2019-06
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.